Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Merck & Co. claims class III antiarrhythmics

May 17, 1996

FK-409 claimed as portal hypertension Rx

May 17, 1996

Endothelin antagonists reported by Shionogi

May 17, 1996

Takeda claims NK1 ligands for respiratory indications

May 17, 1996

Byk Gulden reports PDE IV inhibitors for asthma, dermatoses

May 17, 1996

Pentoxifylline claimed for treating cold symptoms

May 17, 1996

Seven new uses for raloxifene appear in patent literature

May 17, 1996

NMDA antagonists reported by Pfizer

May 17, 1996

Sankyo claims allosteric muscarinic effectors for AD

May 17, 1996

5-HT1D antagonists disclosed by SmithKline Beecham

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...